Article: Drug Firms Settle Lawsuit on Cardizem Generic for $80 Million.

By Julius A. Karash, The Kansas City Star, Mo. Knight Ridder/Tribune Business News

Feb. 19--Aventis Pharmaceuticals and Andrx Corp. have agreed to pay a combined $80 million to settle claims of conspiring to keep a generic form of Cardizem CD off the market.

The money is earmarked for consumers, state agencies and insurance companies that overpaid for the widely used blood pressure medication and its generic equivalents.

The antitrust settlement "continues our mission to protect consumers by fighting prescription drug companies' efforts to manipulate the law to keep cheaper generic drugs off the market," New York Attorney General Eliot ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!